Description
NF 023 is a potent, selective P2X1 purinoceptor antagonist.
Uses
NF023 is a compound that inhibits X-BIR1/TAB1 assembly activity. NF023 can affect cell survival signaling pathways by interfering with XIAP-mediated NF-κB activation. NF023 also shows potential as a selective P2X1 adenylate receptor antagonist. This compound has the potential to synergize with existing pro-apoptotic drugs and play an important role in cancer suppression[1].
References
[1] NF023 binding to XIAP-BIR1: searching drugs for regulation of the NF-κB pathway